Logo - springer
Slogan - springer

Medicine - Urology | Prostate Cancer: A Comprehensive Perspective

Prostate Cancer: A Comprehensive Perspective

Tewari, Ashutosh K (Ed.)

2013, XXXI, 1110 p. 289 illus., 219 illus. in color.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$219.00

(net) price for USA

ISBN 978-1-4471-2864-9

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$279.00

(net) price for USA

ISBN 978-1-4471-2863-2

free shipping for individuals worldwide

online orders shipping within 2-3 days.


add to marked items

  • Prostate Cancer: A Comprehensive Perspective covers every possible aspect of prostate cancer, including: targeted therapeutics; proteomics; molecular imaging and robotic technologies among other things
  •  
  • Divided into sections headed by leading world experts from Europe, USA and Asia
  •  
  • Contains full-color illustrative content

Prostate cancer is the commonest male cancer with over 5 million survivors in US alone. Worldwide, the problem is staggering and has attracted significant attention by media, scientists and cancer experts.

Significant research, discoveries, innovations and advances in treatment of this cancer have produced voluminous literature which is difficult to synthesize and assimilate by the medical community. Prostate Cancer: A Comprehensive Perspective is a comprehensive and definitive source which neatly resolves this problem. It covers relevant literature by leading experts in basic science, molecular biology, epidemiology, cancer prevention, cellular imaging, staging, treatment, targeted therapeutics and innovative technologies.

Prostate Cancer: A Comprehensive Perspective, is a valuable and timely resource for urologists and oncologists.

Content Level » Professional/practitioner

Keywords » Proctology - Prostate Cancer - Urology

Related subjects » Oncology & Hematology - Urology

Table of contents 

 Contents

Foreword

List of Contributors

 

Section 1: Basic Scientific Foundation

Editors: John D. Kelly, Hardev Pandha, Maria Shevchuk, Karl-Dietrich Sievert, and Atsushi Takenaka

 

1. Development, Applied and Surgical Anatomy of the Prostate

Anthony J. Costello and Niall M. Corcoran

 

2. Molecular Biology and Prostate Cancer

Greg L. Shaw and David E. Neal

 

3. Endocrine Mechanisms, Androgen Receptor and Carcinogenesis, Hormone Escape

Kaustubh Datta and Donald Tindall

 

4. Molecular Mechanisms of Castrate Resistant Prostate Cancer

Francois Lamoureux, Amina Zoubeidi, and Martin E. Gleave

 

5. Immunologic Aspects of Prostate Cancer

Christine Galustian, Oussama Elhage, Richard Smith, and Prokar Dasgupta

 

6. Stem Cells in Carcinogenesis of the Prostate

Shi-Ming Tu and Sue-Hwa Lin

 

7. Murine Models of Prostate Cancer

Eric C. Kauffman, Casey K. Ng, and Carrie Rinker-Schaeffer

 

8. Prostate Cancer and the Metabolic Syndrome

Stephen EM Langley and Jenny P. Nobes

 

9. Inflammation and Cancer of the Prostate

Sonya Vasto, Emilio Italiano, Vitale Miceli, and Giuseppe Carruba

 

10. HIV and Prostate Cancer 

Matthew S. Wosnitzer, Jennifer J. Ahn, and Franklin C. Lowe

 

11. Prostate Cancer Genetics

Sashi S. Kommu, Samuel Bishara, and Stephen M. Edwards

 

12. Gene Expression Profiling and Somatic Genome Changes

Michael Ittmann

 

13. The Proteomic Approach to Prostate Cancer

Sashi S. Kommu and Emanual Petricoin

 

14. Epigenetic Changes in Prostate Cancer

William G. Nelson, Michael C. Haffner, Angelo M. De Marzo, and Srinivasan Yegnasubramanian

 

15. Biomarkers of Potential Therapeutic Value

Hideaki Miyake, Atsushi Takenaka, and Masato Fujisawa

 

16. Prostate Tissue Banking

Harveer Dev, Prasanna Sooriakumaran, and Ashutosh Tewari

 

17. Molecular Imaging in Diagnostics

Casey Ng, Eric Kauffman, and Hossein Jadvar

 

18. Molecular Risk Profiling

Neil E. Martin

 

19. Premalignant Lesions of the Prostate

Daniel M. Berney and Anne Y. Warren

 

20. The Pathology of Prostatic Carcinoma

Maria Shevchuk and Brian D. Robinson

 

21. The Pathology of Non-Epithelial Tumors of the Prostate

Maria Shevchuk and Brian D. Robinson

 

22. Neuroendocrine Prostate Cancer

Himisha Beltran, Juan Miguel Mosquera, and Mark A. Rubin

 

Section 2: Epidemiology, Screening, and Chemoprevention

Editors: Neil Fleshner, Cynthia Kuk, William Nelson, and Alexandre Zlotta

 

23. Epidemiology of Prostate Cancer

Ankur M. Manvar, Raj S. Pruthi, Eric. M. Wallen, and Matthew E. Nielsen

 

24. Racial Disparities and the Global Picture

James E. Ferguson III, Matthew Nielsen, Eric Wallen, Raj Pruthi

 

25. Natural History of Prostate Cancer

Paul K. Hegarty and Nicholas J. Hegarty

 

26. Population-Based Health Systems as a Foundation for Prostate Cancer Control Research: The Cancer Research Network

Mark C. Hornbrook and Joan Holup

 

27. Screening for Prostate Cancer

David R. Yates and John B. Anderson

 

28. Next Generation Screening Tests

Jack A. Schalken and Rizal Hamid

 

29. Diet and Prostate Cancer: A Holistic Approach to Management

Philippa J. Cheetham and Aaron E. Katz

 

30. Estrogens in Prostate Cancer

Giuseppe Carruba

 

31. Vitamin D and Prostate Cancer

Naomi Smith and Alejandro Nolazco

 

32. The Role of 5a-Reductase Inhibitors (5-ARIs) in Prostate Cancer Chemoprevention

David Margel and Neil Fleshner

 

33. Other Pharmaceutical Agents in the Chemoprevention of Prostate Cancer

Vivekanandan Kumar

 

Section 3: Diagnosis and Staging

Editors: Peter Carroll and Gary Dorfman

 

34. Early-Detection and Patient Risk Stratification in Prostate Cancer

Rajesh Nair, John Withington, Sukanya Ghosh, and Alastair Henderson

 

35. Tumor Markers

Diederick Duijvesz and Guido Jenster

 

36. Prostate Specific Membrane Antigen-Based Diagnostics

Joseph Osborne, Scott T. Tagawa, Shankar Vallabhajosula, Stanley J. Goldsmith, and Neil H. Bander

 

37. Prostate Specific Membrane Antigen-Based Therapeutics

Scott T. Tagawa, Joseph Osborne, Shankar Vallabhajosula, Stanley J. Goldsmith, and Neil H. Bander

 

38. Presentation and Symptomatology of Prostate Cancer

Agnieszka Michael and Hardev Pandha

 

39. The Role of Ultrasonography

Suzanne van den Heuvel, Paul C.M.S. Verhagen, and Chris H. Bangma

 

40. The Use of Magnetic Resonance Imaging in the Management of Prostate Cancer

Matthieu Durand, Aude Fregeville, Naveen Gumpeni, Abhishek Srivastava, Prasanna Sooriakumaran, Siobhan Gruschow, Niyati Harneja, Kristin M. Saunders, Jean Amiel, and Ashutosh K. Tewari

 

41. The Role of Functional Magnetic Resonance Imaging Techniques

Pieter J. De Visschere, Gert O. De Meerleer, Nicolaas Lumen, and Geert M. Villeirs

 

42. Prostate Biopsy

Paras B. Singh, Caroline M. Moore, and Mark Emberton

 

43. The Staging of Prostate Cancer

Benjamin J. Challacombe and Giles Rottenberg

 

44. Nuclear Medicine in Prostate Cancer

Vinayaka Moorthy Majuran, Vidhiya Vinayakamoorthy, and Derek Svasti-Salee

 

45. Nanotechnology and Prostate Cancer

Sashi S. Kommu, Lidong Qin, Louis Brousseau, Amrith Rao, Philippe Grange, and Mauro Ferrari

 

Section 4: Risk Assessment and Decision-Making Strategies for Localized Prostate Cancer

Editor: Matthew Cooperberg

 

46. Disease Risk Stratification

Alistair Henderson

 

47. Nomograms in Prostate Cancer

Carvell T. Nguyen and Michael W. Kattan

 

48. Comparative Effectiveness of Treatment Alternatives for Localized Prostate Cancer

Matthew R. Cooperberg

 

Section 5: Management of Localized Disease

Editors: Prokar Dasgupta, Alex Mottrie, Abhay Rane, Joseph Smith, Datta Wagle, and Peter Wiklund

 

49. Radical Treatment for Localized Disease: An Overview of Options and Strategies for Decision Making

Joseph A. Smith, Jr.

 

50. Quality of Life and Management of Localized Disease

Andreas E. Nilsson, Gunnar Steineck, and N. Peter Wiklund

 

51. Active Surveillance for Favorable-Risk Prostate Cancer

Nathan Lawrentschuk and Laurence Klotz

 

52. Anesthesia for Robotic-Assisted Prostatectomy

Vinod Malhotra and Peter M. Fleischut

 

53. Retropubic Radical Prostatectomy: The Technique

Hein Van Poppel and Steven Joniau

 

54. Retropubic Radical Prostatectomy: The Results

Wolfgang Horninger and Jasmine Bektic

 

55. Radical Perineal Prostatectomy

Rolf Gillitzer and Joachim W. Thüroff

 

56. Laparoscopic Radical Prostatectomy: The Technique

Christopher Eden and Anthony Hutton

 

57. Laparoscopic Radical Prostatectomy: The Results

Evangelos Liatsikos, Odysseas Andrikopoulos, Panagiotis Kallidonis, and Jens-Uwe Stolzenburg

 

58. Robotic Assisted Radical Prostatectomy: The Technique

Sameer Chopra, Abhishek Srivastava, Prasanna Sooriakumaran, and Ashutosh K. Tewari

 

59. Lymph Node Dissection in Prostate Cancer Surgery

Aaron Bernie, Douglas S. Scherr, and Michael P. Herman

 

60. External Beam Radiotherapy for Low Risk Prostate Cancer

Gert De Meerleer, Piet Ost, Geert Villeirs, Nicolaas Lumen, and Valérie Fonteyne

 

61. Prostate Brachytherapy: Low Dose Rate

Peter Grimm

 

62. Prostate Brachytherapy: High Dose Rate

Carl Salembier and Peter Hoskin

 

63. Intensity Modulated Radiotherapy

Bridget F. Koontz, Devon Godfrey, and W. Robert Lee

 

64. Proton Beam Therapy and Novel Radiotherapeutic Approaches to the Treatment of Prostate Cancer

Jeffrey J. Meyer, Jordan A. Holmes, and Ronald C. Chen

 

65. Prostate Cryotherapy

Mohamed Ismail, Shwan Ahmed, and John Davies

 

66. Focal Therapies for Localized Prostate Cancer

Louise Dickinson, Hashim U. Ahmed, and Mark Emberton

 

Section 6: Failure and Management of Recurrent, Locally Advanced, and Advanced Disease

Editors: Andrew Armstrong, Ronald Chen, Richard Stock, and John Sylvester

 

67. Biochemical Failure in Prostate Cancer

Tian Zhang and Andrew Z. Wang

 

68. The Phenomenon of PSA Bounce After Radiation Therapy

Peter Acher and Rick Popert

 

69. Management of Locally Recurrent Disease

Piet Ost, Valérie Fonteyne, Pieter De Visschere, Nicolaas Lumen, and Gert De Merleer

 

70. Management of High Risk/Locally Advanced Disease

Valérie Fonteyne, Piet Ost, Nicolaas Lumen, Geert Villeirs, and Gert De Meerleer

 

71. Radiotherapy Plus Hormonal Therapy

Jordan A. Holmes and Ronald Chen

 

72. Watchful Waiting in Advanced Prostate Cancer

Maria Carmen Mir and Nathan Lawrentschuk

 

73. Androgen and Androgen Receptor Directed Therapy as Initial Treatment for Prostate Cancer

Bruce Montgomery and Peter S. Nelson

 

74. Hormone-Based Therapies for Castration Resistant Prostate Cancer

Elahe A. Mostaghel and Peter S. Nelson

 

75. Toxicity of Androgen Deprivation Therapy in Hormone Sensitive Prostate Cancer

Naveed H. Akhtar, Elan S. Diamond, Nicole Eiseler, and Scott T. Tagawa

 

76. Chemotherapy and Novel Systemic Approaches in the Treatment of Metastatic Castration Resistant Prostate Cancer

Robyn J. Macfarlane, Chris Hovens, Niall M. Corcoran, and Kim N. Chi

 

77. Immunotherapy

Nicola E. Annels and Hardev Pandha

 

78. Bone Health: Prevention of Skeletal Related Events and Palliative Care

Jean-Baptiste Lattouf and Fred Saad

 

Section 7: Outcomes and Complications After Treatment

Editors: Mark Emberton, Brent Hollenbeck, and Tom Lue

 

79. Assessment of Treatment Outcomes Following Prostate Cancer Therapy

Paul Cathcart and Mark Emberton

 

80. Urinary Incontinence

Ted A. Skolarus

 

81. Erectile Dysfunction

Maarten Albersen and Tom F. Lue

 

82. Immediate/Early Surgical Complications

Thomas J. Walton and Declan G. Murphy

 

83. Population-Based Outcomes Following Treatment of Clinically-Localized Prostate Cancer

Blake Evans and Scott M. Gilbert

 

84. Management of Radiation Adverse Effects

Seth A. Strope

 

85. Management of Complications Following Minimally Invasive Prostate Cancer Therapy

Paul Cathcart and Anthony J. Costello

 

Section 8: Management of Emergencies and Palliative Care

Editors: Steven A. Kaplan and Alexis E. Te

 

86. Prostate Cancer Emergencies

Bethan C. Hickerton, Mohamed Abdulmajed, Manit Arya, and Iqbal S. Shergill

 

87. Management of Bone Metastases

Keen Hun Tai and Farshad Foroudi

 

88. Pain Relief in Metastatic Cancer

Odette Spruyt and Natasha Michael

 

89. The Psycho-Social Impact of Prostate Cancer

Addie Wooten and Heather Siddons

 

90. Nursing Issues in Prostate Cancer

Helen Crowe

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Urology.